Current Consultations

Research Australia regularly contributes to the policy discussions on issues pertinent to Health and Medical Research. This can be through submissions or participating in consultations.

The following lists both consultations and invitations to make submissions which are relevant to health and medical research and/or health and innovation policy in Australia. Research Australia updates this regularly but we may not participate in every one listed.

If you would like more information or you are aware of other consultations that should be included, please contact Greg Mullins, Head of Policy, Research Australia via email or phone (03) 9662 9420.

Please click the heading in the left hand column to access consultation information from the relevant website.



R&D Tax Incentive Amendments Senate Inquiry



On 6 February 2020, the Senate referred the Treasury Laws Amendment (Research and Development Tax Incentive) Bill 2019 to the Economics Legislation Committee for inquiry and report by 30 April 2020.

The Bill would amend the existing R&DTI scheme to, among other things, introduce a cap on the refundable R&DTI that can be claimed by a company (clinical trials are exempted) and an ‘intensity threshold’ that must be satisfied by larger companies.

Research Australia has made a submission, available here. A public hearing has been announced for 31 March in Sydney.


National Stillbirth Action and Implementation Plan


Due 9 April

A Draft Plan is currently open for consultation. Proposed actions in relation to research into Stillbirth are:

·      Develop agreed national research priorities

·      Establish a national placenta biobank

·      Develop a risk stratification tool

·      Publish a collection of Cochrane reviews on stillbirth in the Cochrane Library

·      Develop a comprehensive, publicly accessible register of current research and guidelines relating to stillbirth



WA Health and Medical Life Sciences Industry Growth Plan 2020-2025



Due 10 April

The WA Government is currently undertaking an electronic survey to inform the WA Health and Medical Life Sciences Industry Growth Plan 2020-2025

The Plan will consider activities from ideas generation through to commercialisation. There will be an emphasis on identifying interventions to support product development and business expansion, reduce barriers to commercialisation and open up trade, investment and export opportunities in international markets.